Stock Events

Stock Events

Search...

Ligand Pharmaceuticals (LGND) Q4 2021 Earnings

9NovConfirmed

Q1 2021

Q2 2021

Q3 2021

Q4 2021

1

1.21

1.42

1.63

Details

Expected EPS

1.02

Actual EPS

1.58

Surprise EPS

0.56

Surprise Percent

+54.9%

Description

Ligand Pharmaceuticals (LGND) has reported earnings of 1.58 per share for Q4 2021.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.